Inactive Instrument

Calendar Bachem Holding AG Swiss Exchange

Equities

BANB

CH0012530207

Chart calendar Bachem Holding AG

d966ddc4.J52c9k-i_3qQMFHRhWrZsAHPH-jwf4V0t_jmf6mirEk.XtPWvQiUy0_ycgSJ_A-jwWD-SYeTBrAO9Yy0ONnsmSddqdKYAuOrCeJvBA~99d370a94d63025080abd999de8f7fd4

Upcoming events on Bachem Holding AG

2024-04-21 Swiss Biotech Day
2024-04-23 Annual General Meeting
2024-04-25 Ex-dividend day for final dividend
2024-04-25 Ex-dividend day for Distribution from share premium account
2024-05-13 TIDES USA Conference
2024-06-23 International Oligonucleotides and Peptides Conference
2024-06-25 RNA Therapeutics Symposium
2024-07-14 Nucleic Acids Therapeutics Society of Japan Meeting
2024-07-23 BIO Asia Taiwan Conference
2024-07-25 01:00 am Q2 2024 Earnings Release
2024-08-21 Peptide Therapeutics Forum
2024-08-24 EPS- European Peptide Symposium
2024-09-15 Boulder Peptide Symposium
2024-09-16 Nordic Life Science Days
2024-10-05 Oligonucleotide Therapeutics Society Meeting

Past events on Bachem Holding AG

2024-03-18 TIDES Asia Conference
2024-03-17 BioEurope Spring Conference
2024-03-12 Biologics UK Congress
2024-03-12 RNA Leaders Europe Congress
2024-03-07 05:00 am Q4 2023 Earnings Call
2024-03-07 01:00 am Q4 2023 Earnings Release
2023-07-27 08:00 am Q2 2023 Earnings Call
2023-07-27 01:00 am Q2 2023 Earnings Release
2023-04-20 Ex-dividend day for final dividend
2023-04-20 Ex-dividend day for Distribution from share premium account
2023-03-07 05:00 am Q4 2022 Earnings Call
2023-03-07 01:00 am Q4 2022 Earnings Release
2022-09-20 08:00 am Capital Markets Day
2022-08-25 08:00 am Interim 2022 Earnings Call
2022-08-24 Interim 2022 Earnings Release
2022-05-04 Split: 5 of 1
2022-04-28 Ex-dividend day for final dividend
2022-04-28 Ex-dividend day for Distribution from share premium account
2022-04-28 Ex-dividend day for final dividend
2022-04-28 Ex-dividend day for Distribution from share premium account

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million CHF
Released
Forecast
Spread
314
312
0.47%
402
387
4%
503
510
-1.35%
532
533
-0.27%
577
559
3.3%

618

EBITDA
Million CHF
Released
Forecast
Spread
87,2
88,1
-1.02%
123
115
6.82%
157
163
-3.58%
161
164
-2.03%
167
162
3.13%

181

EBIT
Million CHF
Released
Forecast
Spread
62,4
63,9
-2.42%
96,7
87,4
10.69%
129
134
-3.77%
127
131
-3.12%
129
121
6.53%

148

Earnings before Tax (EBT)
Million CHF
Released
Forecast
Spread
60,4
63,1
-4.3%
91,0
86,0
5.81%
131
134
-1.95%
112
121
-7.5%
124
122
1.89%

148

Net income
Million CHF
Released
Forecast
Spread
54,2
53,3
1.61%
78,1
71,9
8.59%
115
113
1.66%
101
104
-3.59%
112
107
5.03%

127

EPS
CHF
Released
Forecast
Spread
3,91
3,84
1.78%
5,58
5,15
8.43%
8,09
7,94
1.85%
1,37
1,44
-5.01%
1,50
1,44
4.53%

1,67

Announcement Date13/03/2012/03/2118/03/2207/03/2326/02/24-

Quarterly results

Fiscal PeriodDecember 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2
Net sales
Million CHF
Released
Forecast
Spread
179
175
2.22%
177
141
25.72%
225
213
5.69%
239
237
0.86%
264
276
-4.46%
235
250
-5.88%
297
299
-0.63%
240
231
3.97%

325

EBITDA
Million CHF
Released
Forecast
Spread
50,7
50,1
1.2%
53,0
39,4
34.52%
69,6
65,8
5.78%
75,5
73,5
2.72%
81,9
90,0
-9%
67,3
76,2
-11.73%
93,2
96,7
-3.57%
52,5
54,7
-3.98%

113

EBIT
Million CHF
Released
Forecast
Spread
37,9
37,5
1.18%
40,3
26,4
52.5%
56,4
49,8
13.33%
61,9
59,0
5%
67,0
73,7
-9.16%
51,6
59,8
-13.79%
75,7
80,1
-5.48%
34,8
36,4
-4.35%

88,8

Earnings before Tax (EBT)
Million CHF
Released
Forecast
Spread















40,4
58,9
-31.49%
71,7
74,5
-3.73%
36,9
35,1
5.18%



Net income
Million CHF
Released
Forecast
Spread



32,8
22,1
48.56%
45,3
40,8
10.95%
53,1
50,2
5.82%
61,6
62,6
-1.63%
36,6
53,3
-31.24%
64,1
66,6
-3.73%
34,4
28,2
22.02%

76,5

EPS
CHF
Released
Forecast
Spread



2,35
1,58
48.73%
3,23
2,92
10.62%
3,80
3,59
5.85%
4,29
4,39
-2.28%
0,50
0,54
-6.83%
0,87
0,93
-6.45%
0,46
0,38
22.12%

1,02

Announcement Date13/03/2021/08/2012/03/2127/08/2118/03/2225/08/2207/03/2327/07/23-